Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data

被引:22
|
作者
Liner, Kendall [1 ]
Brown, Celeste [2 ]
McGirt, Laura Y. [3 ]
机构
[1] Med Coll Georgia Augusta Hlth, Div Dermatol, Augusta, GA USA
[2] Univ North Carolina Chapel Hill, Carolinas Med Ctr, Sch Med, Charlotte, NC 28203 USA
[3] Levine Canc Inst, Carolinas Med Ctr, Dept Hematol Oncol, Charlotte, NC USA
来源
关键词
mycosis fungoides; nitrogen mustard; mechlorethamine gel; cutaneous T-cell lymphoma; CTCL; Valchlor (R); NITROGEN-MUSTARD THERAPY; CHEMOTHERAPY; EXPERIENCE; MANAGEMENT;
D O I
10.2147/DDDT.S137106
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Nitrogen mustard is a chemotherapeutic agent that has a well-documented safety and efficacy profile in the treatment of cutaneous T-cell lymphoma. Development of nitrogen mustard formulations and treatment regimens has been studied extensively over the last 40 years. In the last 5 years, a new gel formulation has been developed that is associated with a decrease in delayed hypersensitivity reactions. The authors in this review found that while the gel formulation may result in a decrease of allergic contact dermatitis, this advantage has been replaced by a higher number of irritant contact reactions and a decrease in complete response rate. The gel formulation has a complete response rate of 13.8%, which is a decrease in efficacy when compared to aqueous-based preparations of similar concentrations.
引用
收藏
页码:241 / 254
页数:14
相关论文
共 50 条
  • [21] Schedule frequency of chlormethine gel for patients with mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): A real-world evidence study
    Querfeld, Christiane
    Binder, Gary
    Turini, Marco
    Gor, Deval
    Wassel, Christina L.
    Pashos, Chris
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB77 - AB77
  • [22] HEALTHCARE RESOURCE USE IN MYCOSIS FUNGOIDES-TYPE CUTANEOUS T-CELL LYMPHOMA: RESULTS FROM A UK-BASED CLINICIAN QUESTIONNAIRE
    Scarisbrick, J.
    Schmidt, F.
    Turini, M. M.
    D'agostino, P.
    Summers, D.
    van Hest, N.
    Evans, J.
    VALUE IN HEALTH, 2020, 23 : S693 - S694
  • [23] MYCOSIS FUNGOIDES-TYPE CUTANEOUS T-CELL LYMPHOMA (MF-CTCL) EPIDEMIOLOGY AND TREATMENT PATHWAYS IN FRANCE AND SPAIN: NEW INSIGHTS FOR AN ACCURATE DESCRIPTION
    D'Agostino, P.
    Lezzi, C.
    Kent, A.
    Sharp, E.
    Schmidt, F.
    Turini, M. M.
    VALUE IN HEALTH, 2019, 22 : S852 - S853
  • [24] Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma
    Ismail, Sahar A.
    Han, Rujing
    Sanborn, Sharon L.
    Stevens, Seth R.
    Cooper, Kevin D.
    Wood, Gary S.
    Gilliam, Anita C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (04) : 635 - 642
  • [25] Specific Nail Alterations in Cutaneous T-Cell Lymphoma Successful Treatment With Topical Mechlorethamine
    Parmentier, Laurent
    Duerr, Caroline
    Vassella, Erik
    Beltraminelli, Helmut
    Borradori, Luca
    Haneke, Eckart
    ARCHIVES OF DERMATOLOGY, 2010, 146 (11) : 1287 - 1291
  • [26] Maintenance therapy with chlormethine gel among patients with mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): a real-world evidence study
    Querfeld, Christiane
    Turini, Marco
    Gor, Deval
    Angello, James T.
    Pashos, Chris
    Kim, Ellen J.
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S45 - S45
  • [27] Publisher Correction to: Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings
    Ulrike Wehkamp
    Marco Ardigò
    Evangelia Papadavid
    Christiane Querfeld
    Neda Nikbakht
    Advances in Therapy, 2023, 40 : 1299 - 1300
  • [28] Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides) The FLASH Phase 3 Randomized Clinical Trial
    Kim, Ellen J.
    Mangold, Aaron R.
    DeSimone, Jennifer A.
    Wong, Henry K.
    Seminario-Vidal, Lucia
    Guitart, Joan
    Appel, James
    Geskin, Larisa
    Lain, Edward
    Korman, Neil J.
    Zeitouni, Nathalie
    Nikbakht, Neda
    Dawes, Kenneth
    Akilov, Oleg
    Carter, Joi
    Shinohara, Michi
    Kuzel, Timothy M.
    Piette, Warren
    Bhatia, Neal
    Musiek, Amy
    Pariser, David
    Kim, Youn H.
    Elston, Dirk
    Boh, Erin
    Duvic, Madeleine
    Huen, Auris
    Pacheco, Theresa
    Zwerner, Jeffrey P.
    Lee, Seung Tae
    Girardi, Michael
    Querfeld, Christiane
    Bohjanen, Kimberly
    Olsen, Elise
    Wood, Gary S.
    Rumage, Adam
    Donini, Oreola
    Haulenbeek, Andrea
    Schaber, Christopher J.
    Straube, Richard
    Pullion, Christopher
    Rook, Alain H.
    Poligone, Brian
    JAMA DERMATOLOGY, 2022, 158 (09) : 1031 - 1039
  • [29] CYCLOSPORIN-A (CYCLOSPORINE) IN THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA (MYCOSIS-FUNGOIDES)
    KREIS, W
    BUDMAN, DR
    SHAPIRO, PE
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 18 (05) : 1138 - 1140
  • [30] Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience
    Geskin, Larisa J.
    Bagot, Martine
    Hodak, Emmilia
    Kim, Ellen J.
    DERMATOLOGY AND THERAPY, 2021, 11 (04) : 1085 - 1106